Header Logo

Attila Nakeeb

Concepts (466)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Pancreaticoduodenectomy
41
2022
64
5.160
Why?
Pancreatic Neoplasms
46
2023
339
4.240
Why?
Pancreatitis, Acute Necrotizing
23
2022
24
3.690
Why?
Pancreatectomy
36
2023
101
3.450
Why?
Carcinoma, Pancreatic Ductal
20
2023
111
2.150
Why?
Postoperative Complications
26
2023
1284
1.410
Why?
Laparoscopy
13
2021
468
1.290
Why?
Pancreatic Ducts
11
2020
30
1.280
Why?
Adenocarcinoma
15
2022
337
1.270
Why?
Drainage
15
2022
154
1.110
Why?
Retrospective Studies
76
2023
6545
1.070
Why?
Pancreatic Fistula
10
2021
18
1.050
Why?
Adenocarcinoma, Mucinous
9
2019
31
0.980
Why?
Intestinal Fistula
3
2020
10
0.880
Why?
Middle Aged
89
2022
17391
0.850
Why?
Duodenal Diseases
2
2020
15
0.840
Why?
Sphincter of Oddi Dysfunction
3
2023
3
0.800
Why?
Pancreatic Diseases
7
2015
39
0.800
Why?
Mesenteric Veins
2
2020
11
0.790
Why?
Humans
138
2023
62865
0.780
Why?
Pancreatitis
6
2023
97
0.760
Why?
Female
111
2022
32566
0.760
Why?
Gallbladder
12
2007
37
0.720
Why?
Gallstones
3
2020
25
0.710
Why?
Patient Discharge
3
2023
505
0.710
Why?
Aged
66
2022
14268
0.710
Why?
Male
93
2022
29552
0.700
Why?
Nomograms
1
2020
17
0.680
Why?
Pancreas
7
2019
149
0.670
Why?
Vascular Fistula
1
2020
8
0.670
Why?
Crohn Disease
2
2020
111
0.660
Why?
Stomach Neoplasms
1
2020
78
0.650
Why?
Patient Readmission
7
2023
429
0.650
Why?
Adult
60
2022
16672
0.630
Why?
Venous Thrombosis
5
2022
114
0.620
Why?
Cholangiocarcinoma
8
2012
30
0.590
Why?
Choledochostomy
1
2018
3
0.580
Why?
Common Bile Duct
1
2018
19
0.580
Why?
Duodenum
1
2018
42
0.570
Why?
Pancreatic Cyst
6
2018
24
0.570
Why?
Hepatectomy
7
2022
63
0.570
Why?
Bile Duct Neoplasms
7
2012
46
0.550
Why?
Treatment Outcome
36
2023
5596
0.540
Why?
Carcinoma, Papillary
6
2019
35
0.530
Why?
Incidence
19
2022
1373
0.500
Why?
Aged, 80 and over
31
2021
5408
0.470
Why?
Debridement
5
2022
32
0.470
Why?
Palliative Care
8
2017
226
0.460
Why?
Bile Ducts, Intrahepatic
6
2010
26
0.460
Why?
Digestive System Surgical Procedures
3
2023
91
0.450
Why?
Length of Stay
15
2021
805
0.440
Why?
Gastroparesis
3
2019
8
0.420
Why?
Obesity
10
2022
1230
0.410
Why?
Gallbladder Diseases
4
2007
25
0.410
Why?
Laparotomy
3
2021
51
0.410
Why?
Risk Factors
20
2023
5309
0.390
Why?
Survival Rate
16
2020
843
0.380
Why?
Blood Loss, Surgical
3
2018
62
0.350
Why?
Liver Diseases
2
2022
148
0.350
Why?
Neoplasm Invasiveness
12
2018
272
0.350
Why?
Indiana
10
2021
21
0.340
Why?
Tomography, X-Ray Computed
10
2020
1589
0.330
Why?
Bile
6
2019
19
0.330
Why?
Clinical Competence
3
2020
713
0.320
Why?
Surgical Wound Infection
4
2023
114
0.320
Why?
Pancreaticojejunostomy
3
2017
5
0.320
Why?
Sphincterotomy, Transduodenal
3
2023
4
0.320
Why?
Leptin
8
2006
85
0.320
Why?
Insulin Resistance
3
2007
410
0.300
Why?
Colorectal Neoplasms
2
2023
280
0.300
Why?
Cholelithiasis
4
2004
23
0.300
Why?
Muscle, Smooth
3
2019
134
0.290
Why?
Gastrostomy
3
2019
29
0.290
Why?
Biliary Tract Surgical Procedures
2
2010
12
0.290
Why?
Biliary Fistula
2
2020
4
0.280
Why?
Prognosis
12
2020
1727
0.280
Why?
Follow-Up Studies
14
2020
2444
0.270
Why?
Cholangiopancreatography, Endoscopic Retrograde
4
2023
46
0.270
Why?
Prospective Studies
12
2023
3263
0.260
Why?
Splenic Artery
2
2020
9
0.260
Why?
Postoperative Care
3
2018
121
0.260
Why?
Preoperative Care
7
2017
188
0.260
Why?
Gallbladder Neoplasms
1
2006
16
0.260
Why?
Hernia, Ventral
2
2020
25
0.250
Why?
Splenectomy
2
2019
42
0.250
Why?
Gallbladder Emptying
5
2006
5
0.250
Why?
Neuroendocrine Tumors
2
2019
22
0.250
Why?
Necrosis
6
2022
143
0.230
Why?
Logistic Models
6
2020
1275
0.230
Why?
Intestinal Obstruction
2
2020
53
0.230
Why?
Cholesterol
8
2007
259
0.230
Why?
Aneurysm, False
2
2020
50
0.220
Why?
Insulin
3
2006
687
0.220
Why?
Negative-Pressure Wound Therapy
1
2023
12
0.200
Why?
Surgical Wound
1
2023
10
0.200
Why?
Biliary Tract Neoplasms
1
2002
9
0.200
Why?
Cholangitis
2
2019
11
0.200
Why?
Analgesia
1
2022
31
0.200
Why?
Pancreatitis, Chronic
3
2020
19
0.200
Why?
Pain, Postoperative
3
2022
161
0.200
Why?
Dilatation, Pathologic
2
2019
31
0.190
Why?
Neoplasm Staging
7
2017
487
0.190
Why?
Young Adult
11
2020
4655
0.190
Why?
Cystadenoma, Mucinous
2
2017
5
0.190
Why?
Colonic Diseases
1
2022
34
0.190
Why?
Hyperamylasemia
1
2021
1
0.190
Why?
Cholangiopancreatography, Magnetic Resonance
2
2014
10
0.180
Why?
Patient Selection
7
2019
482
0.180
Why?
Disease Progression
4
2022
1159
0.180
Why?
Hypertriglyceridemia
1
2021
8
0.180
Why?
Adolescent
10
2020
6195
0.180
Why?
Internship and Residency
2
2020
788
0.170
Why?
Ursodeoxycholic Acid
1
2020
7
0.170
Why?
Portal Vein
2
2022
38
0.170
Why?
Surgical Mesh
1
2020
61
0.170
Why?
Gastrectomy
1
2020
40
0.170
Why?
Lung Diseases
1
2022
175
0.170
Why?
Pulmonary Embolism
2
2020
171
0.170
Why?
Wound Closure Techniques
1
2020
7
0.170
Why?
Leukocytosis
1
2019
13
0.160
Why?
Pancreatic Pseudocyst
1
2019
12
0.160
Why?
Anti-Bacterial Agents
4
2019
786
0.160
Why?
Amylases
2
2021
12
0.160
Why?
Peritoneal Lavage
1
2019
4
0.160
Why?
Sphincterotomy, Endoscopic
2
2023
7
0.160
Why?
Emergencies
1
2020
115
0.160
Why?
Survivors
1
2020
170
0.160
Why?
Activins
1
2019
54
0.160
Why?
Nurse's Role
1
2020
120
0.160
Why?
Gastrointestinal Hemorrhage
1
2020
79
0.160
Why?
Positron-Emission Tomography
3
2015
208
0.160
Why?
Workload
1
2019
121
0.160
Why?
Constriction, Pathologic
4
2020
120
0.160
Why?
Lipase
2
2021
50
0.150
Why?
Biliary Tract Diseases
1
2019
16
0.150
Why?
Analgesia, Epidural
1
2019
28
0.150
Why?
Stomach
1
2019
86
0.150
Why?
Deoxycytidine
2
2017
42
0.150
Why?
BRCA2 Protein
1
2019
14
0.150
Why?
Cholecystokinin
4
2006
9
0.150
Why?
Time Factors
9
2019
3749
0.150
Why?
DNA Fingerprinting
1
2018
8
0.150
Why?
Dietary Carbohydrates
3
2007
61
0.150
Why?
Travel
1
2018
42
0.150
Why?
Clostridium Infections
1
2019
49
0.150
Why?
Alcohol-Related Disorders
1
2019
38
0.150
Why?
Enteral Nutrition
2
2019
54
0.150
Why?
Cholecystectomy
3
2007
34
0.150
Why?
Practice Patterns, Physicians'
3
2022
709
0.150
Why?
Cholestasis
2
1996
59
0.150
Why?
BRCA1 Protein
1
2019
58
0.150
Why?
Gastric Bypass
1
2019
76
0.150
Why?
Survival Analysis
6
2015
578
0.150
Why?
Choledocholithiasis
1
2018
4
0.150
Why?
Surgeons
1
2021
181
0.150
Why?
Thrombosis
1
2020
199
0.140
Why?
Analgesics
1
2019
103
0.140
Why?
Perioperative Care
1
2019
85
0.140
Why?
Cross Infection
1
2019
160
0.140
Why?
Gastric Mucosa
1
2017
53
0.140
Why?
Ambulatory Care
1
2020
311
0.140
Why?
Medical History Taking
1
2017
67
0.140
Why?
Liver Neoplasms
1
2020
295
0.140
Why?
Cholecystitis
2
2007
29
0.140
Why?
Hepatic Duct, Common
1
2017
7
0.140
Why?
Neoplasm Recurrence, Local
2
2020
337
0.140
Why?
Jejunum
1
2017
14
0.140
Why?
Peripheral Nerves
1
2017
34
0.140
Why?
Patient Care Team
2
2017
337
0.140
Why?
Venous Thromboembolism
1
2019
148
0.140
Why?
Cancer Pain
1
2017
15
0.140
Why?
Abdominal Pain
1
2018
101
0.140
Why?
Carcinoembryonic Antigen
2
1999
32
0.140
Why?
Patient Safety
1
2019
242
0.130
Why?
Anastomotic Leak
1
2017
35
0.130
Why?
Liver Cirrhosis
1
2018
171
0.130
Why?
Antimetabolites, Antineoplastic
1
2017
42
0.130
Why?
Proton Pump Inhibitors
2
2015
42
0.130
Why?
Embolization, Therapeutic
1
2020
314
0.130
Why?
Radiotherapy
1
2017
64
0.130
Why?
Chemoradiotherapy
1
2017
65
0.130
Why?
Patient Education as Topic
1
2020
462
0.130
Why?
Diagnosis, Differential
6
2020
964
0.130
Why?
Blood Glucose
7
2007
485
0.130
Why?
Sphincter of Oddi
3
2019
4
0.120
Why?
Neoplasms, Multiple Primary
1
2015
31
0.120
Why?
Inpatients
1
2018
302
0.120
Why?
Databases, Factual
5
2018
853
0.120
Why?
Fellowships and Scholarships
1
2017
104
0.120
Why?
Lipoma
1
2015
18
0.120
Why?
Adenocarcinoma, Papillary
1
2015
9
0.120
Why?
Gene Expression Profiling
1
2019
769
0.120
Why?
Financing, Organized
1
2015
16
0.120
Why?
Biomarkers, Tumor
4
2014
503
0.120
Why?
Surgical Stapling
1
2015
12
0.120
Why?
Anti-Ulcer Agents
1
2015
9
0.120
Why?
CA-19-9 Antigen
3
2014
10
0.120
Why?
Intubation, Gastrointestinal
3
2021
21
0.120
Why?
Publications
1
2015
29
0.120
Why?
Common Bile Duct Neoplasms
1
1995
5
0.120
Why?
Peptic Ulcer
1
2015
20
0.120
Why?
Splenic Vein
1
2014
2
0.120
Why?
Ampulla of Vater
1
1995
12
0.120
Why?
Hyperlipidemias
2
2006
34
0.120
Why?
Lymph Node Excision
2
2006
42
0.120
Why?
Cystadenoma, Serous
2
2005
4
0.110
Why?
Adenoma
1
2014
68
0.110
Why?
Liver Abscess, Pyogenic
1
2014
1
0.110
Why?
Neoplasms, Cystic, Mucinous, and Serous
1
2014
4
0.110
Why?
Lipids
2
2007
316
0.110
Why?
Autoimmune Diseases
1
2015
231
0.110
Why?
Parasympatholytics
1
2013
7
0.110
Why?
Health Services Accessibility
1
2018
554
0.110
Why?
Continuity of Patient Care
1
2015
173
0.110
Why?
Antidepressive Agents, Tricyclic
1
2013
19
0.110
Why?
Ultrasonography
3
2020
475
0.110
Why?
Genetic Predisposition to Disease
3
2023
716
0.100
Why?
Predictive Value of Tests
5
2020
1078
0.100
Why?
Mutation
2
2019
2598
0.100
Why?
Faculty, Medical
1
2015
198
0.100
Why?
Precancerous Conditions
1
2014
70
0.100
Why?
Catheter Ablation
1
2015
153
0.100
Why?
Bile Ducts
1
2012
25
0.100
Why?
Deep Sedation
1
2012
4
0.100
Why?
Animals
18
2019
20620
0.100
Why?
Body Weight
7
2007
377
0.100
Why?
Body Mass Index
3
2019
864
0.100
Why?
Disease-Free Survival
4
2016
241
0.100
Why?
Antineoplastic Combined Chemotherapy Protocols
4
2022
446
0.090
Why?
Smoking
1
2016
864
0.090
Why?
Natural Orifice Endoscopic Surgery
1
2012
39
0.090
Why?
Mice, Inbred C57BL
10
2007
3389
0.090
Why?
Nitric Oxide Synthase
2
2001
47
0.090
Why?
Liver
3
2012
846
0.090
Why?
Antineoplastic Agents
1
2017
661
0.090
Why?
Anemia, Iron-Deficiency
2
2001
22
0.090
Why?
Chi-Square Distribution
4
2019
416
0.090
Why?
Neoadjuvant Therapy
2
2022
82
0.090
Why?
Reoperation
3
2019
290
0.090
Why?
Crystallization
6
2007
99
0.090
Why?
Anastomosis, Surgical
3
2020
111
0.080
Why?
Mice
13
2019
10819
0.080
Why?
Sensitivity and Specificity
3
2018
1140
0.080
Why?
Treatment Failure
2
2020
199
0.080
Why?
Robotics
1
2010
77
0.080
Why?
Dietary Fats
2
2007
176
0.080
Why?
Social Class
1
2010
133
0.080
Why?
Endosonography
3
2017
26
0.080
Why?
Receptor, Platelet-Derived Growth Factor alpha
2
2019
18
0.080
Why?
Bile Ducts, Extrahepatic
2
2006
3
0.070
Why?
Combined Modality Therapy
3
2017
369
0.070
Why?
Operative Time
2
2019
91
0.070
Why?
Lipid Metabolism
2
2007
220
0.070
Why?
Cholesterol, Dietary
2
2006
29
0.070
Why?
Adipose Tissue
2
2007
296
0.070
Why?
Cholangitis, Sclerosing
2
1999
13
0.070
Why?
Dinoprostone
1
2007
43
0.070
Why?
Risk Assessment
5
2019
2051
0.070
Why?
Proportional Hazards Models
3
2019
729
0.070
Why?
Azetidines
1
2007
8
0.070
Why?
Morbidity
2
2020
113
0.070
Why?
Anticholesteremic Agents
1
2007
35
0.070
Why?
Statistics, Nonparametric
4
2009
213
0.070
Why?
Gastric Outlet Obstruction
1
2007
2
0.070
Why?
Resistin
1
2007
6
0.070
Why?
Pain Measurement
2
2019
343
0.070
Why?
Gastrointestinal Neoplasms
1
2007
33
0.070
Why?
Fibroblasts
2
2019
392
0.070
Why?
Midwestern United States
1
2006
25
0.070
Why?
Multivariate Analysis
2
2014
934
0.060
Why?
Thiazolidinediones
1
2006
50
0.060
Why?
Healthcare Disparities
1
2010
352
0.060
Why?
Hospital Mortality
2
2021
867
0.060
Why?
Biopsy, Fine-Needle
2
2018
63
0.060
Why?
Gene Expression
2
2019
838
0.060
Why?
Radiography, Abdominal
1
2005
26
0.060
Why?
Mice, Obese
4
2006
80
0.060
Why?
United States
4
2020
7744
0.060
Why?
Dissection
1
2005
48
0.060
Why?
Early Detection of Cancer
2
2023
315
0.060
Why?
Case-Control Studies
2
2021
1115
0.060
Why?
Cystadenoma
1
2004
6
0.060
Why?
Intestine, Small
1
2005
79
0.060
Why?
Hypoglycemic Agents
1
2006
214
0.060
Why?
Pylorus
1
2004
10
0.060
Why?
Magnetic Resonance Imaging
4
2019
2150
0.060
Why?
Acetylcholine
4
2006
44
0.050
Why?
Myocytes, Smooth Muscle
1
2004
60
0.050
Why?
Adenoma, Islet Cell
1
2003
4
0.050
Why?
Cohort Studies
4
2011
2549
0.050
Why?
Preoperative Period
2
2017
69
0.050
Why?
Chemotherapy, Adjuvant
2
2017
85
0.050
Why?
Recurrence
3
2014
636
0.050
Why?
Mice, Inbred NOD
1
2004
521
0.050
Why?
Severity of Illness Index
2
2022
1541
0.050
Why?
Carcinoma
1
2004
125
0.050
Why?
Germ-Line Mutation
1
2023
45
0.050
Why?
Stents
1
2007
487
0.050
Why?
Muscle Contraction
2
2019
202
0.050
Why?
Diet
1
2006
523
0.050
Why?
Diabetes Mellitus
2
2004
536
0.050
Why?
Acute Disease
1
2023
671
0.050
Why?
Ileum
1
2001
22
0.050
Why?
Biomarkers
2
2019
1388
0.050
Why?
Decompression
1
2021
1
0.050
Why?
Gastric Emptying
1
2021
6
0.050
Why?
Organ Size
3
2007
171
0.050
Why?
North America
2
2012
111
0.050
Why?
Gastric Fistula
1
2020
4
0.040
Why?
Exocrine Pancreatic Insufficiency
1
2020
7
0.040
Why?
Splanchnic Circulation
1
2020
16
0.040
Why?
Propensity Score
1
2021
154
0.040
Why?
Heparin, Low-Molecular-Weight
1
2020
25
0.040
Why?
Factor Xa Inhibitors
1
2020
35
0.040
Why?
Kaplan-Meier Estimate
2
2012
418
0.040
Why?
Carcinoma, Renal Cell
1
2001
93
0.040
Why?
Immunohistochemistry
2
2019
890
0.040
Why?
Genotype
1
2002
666
0.040
Why?
Herniorrhaphy
1
2020
69
0.040
Why?
Health Plan Implementation
1
2020
40
0.040
Why?
Triglycerides
3
2007
244
0.040
Why?
Retreatment
1
2020
47
0.040
Why?
Leukocyte Count
1
2019
96
0.040
Why?
Odds Ratio
1
2022
769
0.040
Why?
Kidney Neoplasms
1
2001
145
0.040
Why?
Efficiency
1
2019
39
0.040
Why?
Cachexia
1
2019
9
0.040
Why?
Activin Receptors, Type II
1
2019
9
0.040
Why?
Heparin
1
2020
116
0.040
Why?
Colectomy
1
2020
108
0.040
Why?
Body Weights and Measures
1
2019
33
0.040
Why?
Syndrome
1
2019
179
0.040
Why?
Actuarial Analysis
2
1999
17
0.040
Why?
Intraoperative Care
1
2019
38
0.040
Why?
Lymphoma
1
2000
101
0.040
Why?
Muscular Atrophy
1
2019
26
0.040
Why?
Failure to Thrive
1
2019
8
0.040
Why?
Centralized Hospital Services
1
2018
6
0.040
Why?
Fatigue
1
2019
112
0.040
Why?
Genes, ras
1
1998
27
0.040
Why?
Nurses
1
2020
104
0.040
Why?
Reference Values
1
2019
335
0.040
Why?
Genes, p53
1
1998
52
0.040
Why?
Hospitals, High-Volume
1
2018
32
0.040
Why?
Islets of Langerhans
1
2020
279
0.040
Why?
Muscle Fibers, Skeletal
1
2019
93
0.040
Why?
Renal Insufficiency
1
2019
67
0.040
Why?
Quality of Life
2
2023
1221
0.040
Why?
Heterozygote
1
2019
168
0.040
Why?
Age Factors
2
2016
1556
0.040
Why?
Anticoagulants
1
2022
495
0.040
Why?
Progesterone
1
1999
163
0.040
Why?
Interstitial Cells of Cajal
1
2017
2
0.040
Why?
Proto-Oncogene Proteins c-sis
1
2017
5
0.040
Why?
Chronic Pain
1
2020
150
0.040
Why?
Genetic Testing
1
2019
131
0.040
Why?
Heme Oxygenase-1
1
2017
20
0.040
Why?
Stem Cell Factor
1
2017
26
0.040
Why?
Program Evaluation
1
2020
486
0.040
Why?
Neoplasm Grading
1
2017
86
0.040
Why?
Anoctamin-1
1
2017
16
0.040
Why?
Clinical Decision-Making
1
2019
160
0.040
Why?
Obesity, Morbid
1
2019
97
0.030
Why?
Conversion to Open Surgery
1
2017
9
0.030
Why?
Disease Management
1
2019
234
0.030
Why?
Double-Blind Method
1
2019
739
0.030
Why?
Analgesics, Opioid
1
2022
532
0.030
Why?
Failure to Rescue, Health Care
1
2017
5
0.030
Why?
Endoscopy
1
2017
109
0.030
Why?
Disease Models, Animal
2
2019
2179
0.030
Why?
Random Allocation
2
2012
198
0.030
Why?
Fatty Acids, Nonesterified
2
2007
56
0.030
Why?
Phospholipids
2
2007
81
0.030
Why?
Choledochal Cyst
1
1996
3
0.030
Why?
Enzyme-Linked Immunosorbent Assay
2
2007
455
0.030
Why?
Universities
1
2017
157
0.030
Why?
Neoplasm Proteins
1
2017
283
0.030
Why?
Dogs
2
2012
325
0.030
Why?
Surgery Department, Hospital
1
2015
21
0.030
Why?
Quality of Health Care
1
2019
517
0.030
Why?
Kidney Diseases
1
2017
174
0.030
Why?
Neuropeptide Y
2
2006
13
0.030
Why?
Jejunostomy
2
2010
7
0.030
Why?
Cell Line, Tumor
1
2019
1455
0.030
Why?
Histamine H2 Antagonists
1
2015
15
0.030
Why?
National Institutes of Health (U.S.)
1
2015
116
0.030
Why?
Alkaline Phosphatase
1
2014
46
0.030
Why?
Radiotherapy, Adjuvant
2
2010
59
0.030
Why?
Early Termination of Clinical Trials
1
2014
5
0.030
Why?
Hospitalization
1
2022
1346
0.030
Why?
False Negative Reactions
1
2014
40
0.030
Why?
Early Diagnosis
1
2014
96
0.030
Why?
Neurotransmitter Agents
2
2004
42
0.030
Why?
False Positive Reactions
1
2014
78
0.030
Why?
Drug Resistance
2
2004
152
0.030
Why?
Quality Improvement
1
2017
439
0.020
Why?
Peptide Fragments
2
2006
411
0.020
Why?
Decision Support Techniques
1
2014
194
0.020
Why?
Sciuridae
2
2001
3
0.020
Why?
Reproducibility of Results
2
2007
1640
0.020
Why?
RNA, Messenger
1
2017
1534
0.020
Why?
Randomized Controlled Trials as Topic
1
1995
730
0.020
Why?
Ligation
1
2011
38
0.020
Why?
Heart Failure
1
2019
901
0.020
Why?
Practice Guidelines as Topic
1
2015
727
0.020
Why?
Health Care Costs
1
2012
209
0.020
Why?
Algorithms
2
2010
1003
0.020
Why?
Minimally Invasive Surgical Procedures
1
2011
122
0.020
Why?
Down-Regulation
2
2001
318
0.020
Why?
Fluorouracil
1
2010
66
0.020
Why?
Florida
1
2010
48
0.020
Why?
Blotting, Western
2
2001
610
0.020
Why?
Feasibility Studies
1
2012
562
0.020
Why?
Analysis of Variance
1
2011
608
0.020
Why?
Contraindications
1
2009
49
0.020
Why?
Academic Medical Centers
1
2011
317
0.020
Why?
Cost-Benefit Analysis
1
2010
309
0.020
Why?
Signal Transduction
1
2019
3027
0.020
Why?
Postoperative Period
1
2009
138
0.020
Why?
Ezetimibe
1
2007
6
0.020
Why?
Cholesterol Esters
1
2007
10
0.020
Why?
Poverty
1
2010
295
0.020
Why?
Radiographic Image Interpretation, Computer-Assisted
1
2007
71
0.020
Why?
Viscera
1
2007
10
0.020
Why?
Sodium
1
2007
62
0.020
Why?
Osmolar Concentration
1
2007
89
0.020
Why?
Cholinergic Agents
1
2006
9
0.020
Why?
Decision Making
1
2010
402
0.020
Why?
Angiography
1
2007
151
0.020
Why?
Comorbidity
1
2010
1119
0.020
Why?
Butter
1
2006
1
0.020
Why?
Radiography, Interventional
1
2007
74
0.020
Why?
Mice, Inbred Strains
1
2006
189
0.020
Why?
Barium Sulfate
1
2005
18
0.010
Why?
Enema
1
2005
14
0.010
Why?
Mice, Mutant Strains
1
2004
302
0.010
Why?
Spleen
1
2005
482
0.010
Why?
Vacuoles
1
2003
26
0.010
Why?
Phenotype
1
2007
1197
0.010
Why?
Cytokines
1
2007
934
0.010
Why?
Diabetes Complications
1
2003
106
0.010
Why?
Dose-Response Relationship, Drug
1
2004
863
0.010
Why?
Contrast Media
1
2005
421
0.010
Why?
Receptors, Vasoactive Intestinal Peptide
1
2001
1
0.010
Why?
Nitroarginine
1
2001
2
0.010
Why?
Vasoactive Intestinal Peptide
1
2001
17
0.010
Why?
Nitric Oxide Synthase Type I
1
2001
7
0.010
Why?
Iron, Dietary
1
2001
9
0.010
Why?
Electric Stimulation
1
2001
140
0.010
Why?
Cytodiagnosis
1
2001
46
0.010
Why?
Hemoglobins
1
2001
135
0.010
Why?
Vincristine
1
2000
27
0.010
Why?
Cyclophosphamide
1
2000
79
0.010
Why?
Prednisone
1
2000
86
0.010
Why?
Doxorubicin
1
2000
99
0.010
Why?
Lymphoma, Large B-Cell, Diffuse
1
2000
68
0.010
Why?
Diabetes Mellitus, Type 1
1
2004
620
0.010
Why?
Enzyme Inhibitors
1
2001
373
0.010
Why?
West Virginia
1
1998
6
0.010
Why?
Cause of Death
1
1999
222
0.010
Why?
Linear Models
1
1999
409
0.010
Why?
Inflammatory Bowel Diseases
1
1999
101
0.010
Why?
Liver Transplantation
1
1999
215
0.010
Why?
Tumor Suppressor Protein p53
1
1998
303
0.010
Why?
Diagnostic Imaging
1
1999
262
0.010
Why?
Child
1
1999
4477
0.000
Why?
Nakeeb's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (466)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_